Tumor Profiling Global Market Report 2025

Description

Tumor profiling is a collection of methods used to examine and characterize the genetic and molecular characteristics of a tumor. This process helps identify specific mutations, gene expression patterns, and other molecular traits of cancer cells, providing valuable insights into the biology of the tumor. It also aids in treatment decision-making and supports the development of personalized therapies.

The primary techniques used in tumor profiling include genomics, proteomics, epigenetics, and metabolomics. Genomics involves studying the genetic material (DNA) of cancer cells to identify genetic alterations that drive tumor formation and progression. It uses technologies such as sequencing, quantitative polymerase chain reaction (qPCR), immunohistochemistry, in situ hybridization (ISH), and microarrays. These techniques are commonly applied in personalized cancer treatment, oncological diagnostics, and research.

The tumor profiling market research report is one of a series of new reports from The Business Research Company that provides tumor profiling market statistics, including tumor profiling industry global market size, regional shares, competitors with a tumor profiling market share, detailed tumor profiling market segments, market trends and opportunities, and any further data you may need to thrive in the tumor profiling industry. This tumor profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor profiling market size has grown rapidly in recent years. It will grow from $10.16 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historic period can be attributed to several factors, including the rising prevalence of cancer cases, growing demand for personalized medicine, increased healthcare spending, wider adoption of companion diagnostics, and heightened awareness of the importance of early cancer detection.

The tumor profiling market size is expected to see rapid growth in the next few years. It will grow to $16.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated during the forecast period can be attributed to factors such as the increasing adoption of liquid biopsy techniques, rising investments in cancer research and development, an aging population, the expanding use of targeted therapies, and a growing number of cancer research collaborations. Key trends expected to shape this period include a shift toward companion diagnostics, an increase in multi-gene testing, technological innovations in next-generation sequencing, the integration of artificial intelligence (AI) in cancer diagnostics, and advancements in tumor profiling technologies.

The growing demand for personalized medicine is expected to fuel the growth of the tumor profiling market in the coming years. Personalized medicine tailors healthcare treatments to the unique characteristics of each patient, offering more precise therapies with better outcomes and fewer side effects compared to traditional treatments. Tumor profiling plays a key role in personalized medicine by identifying specific genetic mutations and biomarkers in a patient's tumor, enabling targeted therapies that minimize side effects. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based organization focused on advancing personalized medicine, reported that personalized medicines accounted for over one-third of all new drug approvals in 2023, marking the fourth consecutive year of this trend. As a result, the rising demand for personalized medicine is driving the expansion of the tumor profiling market.

Leading companies in the tumor profiling market are increasingly focusing on developing advanced solutions, including artificial intelligence (AI)-powered diagnostic tools, to improve the accuracy and efficiency of cancer treatment. AI involves the use of advanced computational techniques to analyze complex genomic, proteomic, and clinical data, facilitating faster diagnoses, personalized treatment plans, and better disease progression monitoring. For example, in January 2025, Panakeia Technologies LTD, a UK-based company specializing in AI-driven software for cancer diagnosis and treatment, introduced PANProfiler Colon. This AI-powered software is specifically designed to profile key molecular biomarkers, such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR), using H and E-stained images of colon cancer tissue samples. The tool allows for rapid and precise molecular profiling of tumors, which is crucial for diagnosing colorectal cancer, identifying Lynch syndrome, and guiding personalized treatment decisions.

In February 2024, Myriad Genetics Inc., a U.S.-based leader in genetic testing and precision medicine, acquired assets from Intermountain Precision Genomics (IPG) for an undisclosed amount. This acquisition bolsters Myriad's precision oncology portfolio by incorporating IPG's precise tumor test, precise liquid test, and its CLIA-certified laboratory in St. George, Utah, all aimed at advancing patient care. Intermountain Precision Genomics is a US-based division specializing in molecular diagnostics, genomic testing, and tumor profiling.

Major players in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., and Predictive Oncology Inc.

North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tumor profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tumor profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor profiling market includes revenues earned by entities by providing services such as biomarker testing, methylation profiling, and clinical trial matching. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor profiling market also includes sales of liquid biopsy kits, immunohistochemistry (IHC) kits, and methylation profiling kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics
2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray
3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research
Subsegments:
1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing
2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting
3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis
4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35611

1. Executive Summary

2. Tumor Profiling Market Characteristics

3. Tumor Profiling Market Trends And Strategies

4. Tumor Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tumor Profiling Growth Analysis And Strategic Analysis Framework

5.1. Global Tumor Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tumor Profiling Market Growth Rate Analysis
5.4. Global Tumor Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tumor Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tumor Profiling Total Addressable Market (TAM)

6. Tumor Profiling Market Segmentation

6.1. Global Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomics
Proteomics
Epigenetics
Metabolomics
6.2. Global Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencing Techniques
Quantitative Polymerase Chain Reaction (qPCR)
Immunohistochemistry
In Situ Hybridization (ISH)
Microarray
6.3. Global Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Personalized Cancer Medicine
Oncological Diagnostics
Research
6.4. Global Tumor Profiling Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarrays
Sanger sequencing
6.5. Global Tumor Profiling Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass Spectrometry (MS)
Protein Microarrays
Immunohistochemistry (IHC)
Western Blotting
6.6. Global Tumor Profiling Market, Sub-Segmentation Of Epigenetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DNA Methylation Analysis
Chromatin Immunoprecipitation Sequencing (ChIP-seq)
Histone Modification Profiling
Non-Coding RNA Analysis
6.7. Global Tumor Profiling Market, Sub-Segmentation Of Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nuclear Magnetic Resonance (NMR) Spectroscopy
Gas Chromatography-Mass Spectrometry (GC-MS)
Liquid Chromatography-Mass Spectrometry (LC-MS)
Capillary Electrophoresis-Mass Spectrometry (CE-MS)

7. Tumor Profiling Market Regional And Country Analysis

7.1. Global Tumor Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tumor Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Profiling Market

8.1. Asia-Pacific Tumor Profiling Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Profiling Market

9.1. China Tumor Profiling Market Overview
9.2. China Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Profiling Market

10.1. India Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Profiling Market

11.1. Japan Tumor Profiling Market Overview
11.2. Japan Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Profiling Market

12.1. Australia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Profiling Market

13.1. Indonesia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Profiling Market

14.1. South Korea Tumor Profiling Market Overview
14.2. South Korea Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Profiling Market

15.1. Western Europe Tumor Profiling Market Overview
15.2. Western Europe Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Profiling Market

16.1. UK Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Profiling Market

17.1. Germany Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Profiling Market

18.1. France Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Profiling Market

19.1. Italy Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Profiling Market

20.1. Spain Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Profiling Market

21.1. Eastern Europe Tumor Profiling Market Overview
21.2. Eastern Europe Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Profiling Market

22.1. Russia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Profiling Market

23.1. North America Tumor Profiling Market Overview
23.2. North America Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Profiling Market

24.1. USA Tumor Profiling Market Overview
24.2. USA Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Profiling Market

25.1. Canada Tumor Profiling Market Overview
25.2. Canada Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Profiling Market

26.1. South America Tumor Profiling Market Overview
26.2. South America Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Profiling Market

27.1. Brazil Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Profiling Market

28.1. Middle East Tumor Profiling Market Overview
28.2. Middle East Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Profiling Market

29.1. Africa Tumor Profiling Market Overview
29.2. Africa Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Profiling Market Competitive Landscape And Company Profiles

30.1. Tumor Profiling Market Competitive Landscape
30.2. Tumor Profiling Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Profiling Market Other Major And Innovative Companies

31.1. Sysmex Corporation
31.2. QIAGEN N.V.
31.3. Exact Sciences Corporation
31.4. Guardant Health Inc.
31.5. GenScript Biotech Corporation
31.6. NeoGenomics Inc.
31.7. Caris Life Sciences Inc.
31.8. Tempus Inc.
31.9. Foundation Medicine Inc.
31.10. NanoString Technologies Inc.
31.11. Personalis Inc.
31.12. Boreal Genomics Inc.
31.13. Strand Life Sciences Pvt. Ltd.
31.14. HTG Molecular Diagnostics Inc.
31.15. Lucence Health Inc.

32. Global Tumor Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Profiling Market

34. Recent Developments In The Tumor Profiling Market

35. Tumor Profiling Market High Potential Countries, Segments and Strategies

35.1 Tumor Profiling Market In 2029 - Countries Offering Most New Opportunities
35.2 Tumor Profiling Market In 2029 - Segments Offering Most New Opportunities
35.3 Tumor Profiling Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer